High frequency of oncogenic BRAF mutations has important clinical implications and multiple studies have shown that BRAFV600E correlates with aggressive features of thyroid cancer such as extrathyroidal extensions, vascular invasion, larger thyroid nodule size, advanced staging, lymph node metastasis and recurrence (77). Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.